Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment

NCT00090259 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00090259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00090259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
December 19, 2001
Completion date
May 13, 2009
Enrollment
3,834 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure